Protara Therapeutics (TARA) Stock Chart & Stock Price History $3.06 -0.04 (-1.29%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$3.15 +0.09 (+2.91%) As of 08/1/2025 05:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Protara Therapeutics Stock Price Performance The Protara Therapeutics (TARA) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 50.00%, with a year-to-date return of -42.05%. In the past month, the stock has increased 10.07%, reflecting recent market activity. As of the latest close, Protara Therapeutics traded at $3.06 with a market cap of $118.06 million and volume of 301,824 shares. Five years ago, the stock traded at $24.94, representing a 87.73% decrease over that period. At the time, it had a market cap of $149.64 million and a volume of 21,839 shares. Receive TARA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Protara Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-8.66%1 Month Performance+10.07%3 Month Performance-14.53%Year-To-Date Performance-42.05%1 Year Performance+50.00%5 Year Performance-87.73% TARA Stock Chart for Saturday, August, 2, 2025 TARA Chart by TradingView Protara Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/01/2025$3.10$3.06-1.29%$3.28$3.01301,824 shs$118.06 million07/31/2025$3.18$3.10-2.52%$3.26$3.09126,754 shs$119.60 million07/30/2025$3.33$3.18-4.50%$3.44$3.15357,881 shs$122.68 million07/29/2025$3.35$3.33-0.60%$3.44$3.27209,916 shs$128.48 million07/28/2025$3.33$3.35+0.60%$3.57$3.34377,892 shs$129.24 million07/25/2025$3.34$3.33-0.30%$3.36$3.27111,494 shs$128.47 million07/24/2025$3.39$3.34-1.47%$3.40$3.3396,346 shs$128.86 million07/23/2025$3.33$3.39+1.80%$3.45$3.25241,420 shs$130.79 million07/22/2025$3.42$3.33-2.63%$3.45$3.26287,001 shs$128.47 million07/21/2025$3.08$3.42+11.04%$3.43$3.09299,689 shs$131.94 million Get the Latest News and Ratings for TARA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Protara Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/18/2025$3.14$3.08-1.91%$3.20$3.07123,405 shs$118.83 million07/17/2025$3.15$3.14-0.32%$3.20$3.12119,991 shs$121.14 million07/16/2025$3.05$3.15+3.28%$3.18$3.06170,385 shs$121.53 million07/15/2025$3.16$3.05-3.48%$3.23$3.03180,801 shs$117.67 million07/14/2025$3.05$3.16+3.61%$3.17$3.02105,834 shs$121.91 million07/11/2025$3.12$3.05-2.24%$3.21$3.03118,189 shs$117.67 million07/10/2025$3.22$3.12-3.11%$3.22$3.12138,521 shs$120.38 million07/09/2025$3.03$3.22+6.27%$3.23$3.00357,934 shs$124.23 million07/08/2025$2.80$3.03+8.21%$3.04$2.81293,004 shs$116.90 million07/07/2025$2.91$2.80-3.65%$2.94$2.80341,523 shs$108.02 million07/04/2025$2.91$2.91$2.92$2.80133,655 shs$112.11 million07/03/2025$2.78$2.91+4.53%$2.92$2.80133,655 shs$112.12 million07/02/2025$2.80$2.78-0.71%$2.87$2.77337,757 shs$107.25 million07/01/2025$3.03$2.80-7.59%$3.10$2.79531,406 shs$108.02 million Related Companies RAPP Stock Price Chart OPT Stock Price Chart ORKA Stock Price Chart SLDB Stock Price Chart TERN Stock Price Chart SIGA Stock Price Chart TRML Stock Price Chart RZLT Stock Price Chart KMDA Stock Price Chart PRTC Stock Price Chart Receive TARA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Protara Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:TARA) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredIf you saw this, you'd be scared tooMarkets may look strong—but one veteran analyst warns we’re nearing a financial breaking point. After 40+ y...InvestorPlace | SponsoredTurn $1K into $50K with This DeFi GemBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Protara Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Protara Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
